Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Balk, Steven P

Class:IdPerson:2460041
_displayNameBalk, Steven P
_timestamp2012-08-30 12:42:34
created[InstanceEdit:2460053] Orlic-Milacic, M, 2012-08-30
firstnameSteven P
initialSP
surnameBalk
(author)[LiteratureReference:2460026] Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits
[LiteratureReference:8850289] Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule
[LiteratureReference:9694089] AR and ER interaction with a p21-activated kinase (PAK6)
[LiteratureReference:9707025] Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors
[LiteratureReference:9912120] EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
[Change default viewing format]
No pathways have been reviewed or authored by Balk, Steven P (2460041)